Lentiviral Vectors Patent - Oxford BioMedica (UK) Limited EP4118217A1
Summary
The European Patent Office published patent application EP4118217A1 for Oxford BioMedica (UK) Limited covering lentiviral vectors (IPC C12N 15/86). Jordan Wright is listed as the inventor. The patent designates all listed European member states including DE, FR, GB, IT, ES, NL, BE, CH, and others. Patent grants provide exclusive commercial rights to the holder.
What changed
The European Patent Office published patent EP4118217A1 for Oxford BioMedica (UK) Limited covering lentiviral vectors under IPC classification C12N 15/86. The patent application was published on April 8, 2026 and designates multiple European member states.
Oxford BioMedica gains exclusive commercial rights to this lentiviral vector technology across all designated European countries for the standard 20-year patent term. Competitors in the gene therapy and cell therapy sectors should be aware of this granted patent position when developing related products in Europe.
Archived snapshot
Apr 18, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
LENTIVIRAL VECTORS
Publication EP4118217A1 Kind: A1 Apr 08, 2026
Applicants
Oxford BioMedica (UK) Limited
Inventors
WRIGHT, Jordan
IPC Classifications
C12N 15/86 20060101AFI20210917BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Biotech (C12N)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Biotech (C12N) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.